A Phase II Study of Neratinib in Metastatic HER2 Non-amplified by HER2 Mutant Breast Cancer
Research Grant
Awarded By
Washington University
Start Date
January 1, 2014
End Date
December 31, 2023
Awarded By
Washington University
Start Date
January 1, 2014
End Date
December 31, 2023